Benoit Gravel
Vermögen: 238 262 $ am 31.05.2026
Vermögen: 238 262 $ am 31.05.2026
Benoit Gravel currently works at Medexus Pharmaceuticals, Inc., as Independent Director from 2017.
Mr. Gravel also formerly worked at The Public Sector Pension Investment Board, as Chairman, Tm Bioscience Corp., as Director, Lumira Capital Investment Management, Inc., as Director, Rhone-Poulenc Canada, Inc., as Director-Corporate Planning & Business Development from 1995 to 2000, Zentiva Group as, as Vice President-Global Portfolio Management from 2014 to 2016, Aventis Pasteur Ltd., as Vice President-Commercial Affairs, Sanofi Canada, Inc., as VP-Diabetes & Specialized Care Unit from 2012 to 2014, and Gerson Lehman Group (Asia) Ltd., as Member-Healthcare Council from 2016 to 2022.
Mr. Gravel received his undergraduate degree and graduate degree from the University of Montréal.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.12.2025 | 85.368 ( 0,26 % ) | 238 262 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 22.09.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
Gerson Lehman Group (Asia) Ltd. | Corporate Officer/Principal | 01.01.2022 |
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Corporate Officer/Principal | 01.02.2016 |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01.01.2014 |
Rhone-Poulenc Canada, Inc.
Rhone-Poulenc Canada, Inc. Financial ConglomeratesFinance Part of Sanofi, Rhone-Poulenc Canada, Inc. is a company based in Mississauga, Canada. | Corporate Officer/Principal | 01.01.2000 |
Aventis Pasteur Ltd. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Tm Bioscience Corp.
Tm Bioscience Corp. BiotechnologyHealth Technology Develops diagnostic tests including tests for genetic disorders, drug metabolism and infectious diseases | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Manufactures, develops and markets generics & pharmaceutical products | Health Technology |
The Public Sector Pension Investment Board
The Public Sector Pension Investment Board Financial ConglomeratesFinance PSP Investments is a long-term manager which manages a diversified global portfolio composed of investments in public financial markets, private equity, real estate, infrastructure, natural resources and private debt. The firm is committed to minimizing risks and maximizing returns. To realize this objective, they have developed an integrated approach to managing the full spectrum of risks across their enterprise. | Finance |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aventis Pasteur Ltd. | |
Rhone-Poulenc Canada, Inc.
Rhone-Poulenc Canada, Inc. Financial ConglomeratesFinance Part of Sanofi, Rhone-Poulenc Canada, Inc. is a company based in Mississauga, Canada. | Finance |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Health Technology |
Gerson Lehman Group (Asia) Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen